Showing Results for: “exercise”

Sun Life U.S. has renewed its national collaboration with the American Diabetes Association® (ADA), continuing its support of Project Power for youth, a comprehensive national initiative designed to engage, educate and empower young people to embrace healthier lifestyles. The goal of the program is to help reduce the risk of obesity and type 2 diabetes. Support of the ADA and diabetes programming is part of Sun Life's focus on broadening access to health services and programs for communities at higher risk for developing diabetes. Through this two-year renewal, Sun Life will invest $125,000

Feeling overwhelmed after a diabetes diagnosis? Discover tools, tips, and support for managing type 1 or type 2 diabetes through diet, exercise, medication, and self-care. Start living healthier today!

Learn about diabetic neuropathy, its different types, and treatments. Discover ways to manage and prevent nerve damage complications from diabetes.

Agne Kisonaite is a professional artist who transforms everyday objects into creative art & design. Her work includes paintings, sculptures, furniture and handmade rug designs as well as art venue staging. Agne won the Lithuanian National Design Prize in 2015, and in the same year her art object ‘Lipstick Tower’ shown in Hong Kong achieved a Guinness World Record. Agne dedicates part of her efforts to projects looking at improving the lives of those affected by diabetes. You can visit Agne's portfolio at agneart.com . This is her story: 2012 was the year I’ll never forget. It was a mix of

Sydney Williams is a founder, author, speaker, hike leader, outdoor advocate and self-described feeler of feelings. This is her story: Diabetes is the Best Thing That Ever Happened to Me Every November, I like to reflect on the past year and think about what I'm thankful for. This is the third November where the thing I'm most thankful for is being diagnosed with Type 2 Diabetes. When I was diagnosed with T2D in September 2017, I took it as a challenge. I've been a people pleaser my entire life, and I channeled that into being the best diabetes patient my doctor has ever seen. I am an

Linagliptin, when added to usual diabetes care in people with type 2 diabetes (T2D) with increased risk of cardiovascular (CV) and/or renal disease, resulted in incidences of CV and renal events comparable to placebo over a median period of 2.2 years across a broad range of age and kidney function status, according to a symposium presentation today titled “Linagliptin Trial in Type 2 Diabetes Mellitus at High Cardiovascular Risk with Chronic Kidney Disease,” at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone Convention Center in San Francisco

Study presented at ADA’s Scientific Sessions compared insulin-only mode of iLet to usual care The iLet bionic pancreas (BP)¹ significantly increased the percentage of time adults with type 1 diabetes (T1D) had glucose levels between 70–180 mg/dl, when compared to usual care (UC) therapy of either multiple daily insulin injections (MDI) or continuous subcutaneous insulin infusion (CSII), according to the study, “First Human Study Testing the iLet, a Purpose-Built Bionic Pancreas Platform,” presented today at the American Diabetes Association’s® (ADA’s) 79th Scientific Sessions® at the Moscone

In recent years, diabetes technology has evolved at a rapid pace, and the use of insulin pumps and continuous glucose monitoring (CGM) systems has grown tremendously. To foster a more active role in diabetes management among youth, professionals encourage consistent utilization of monitoring tools across multiple environments. A professional interest group presentation entitled “Diabetes Technology Use in Schools, Camps, and Emergency Rooms,” focused on the use of diabetes technology for children and adolescents in a variety of settings, today at the American Diabetes Association’s® (ADA’s)